reference/24091150

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24091150

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Comparative Study\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, P.H.S.
endingPage	2453
issn	0085-2538
issueIdentifier	6
pageRange	2446-2453
publicationName	Kidney International
startingPage	2446
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a2828c5cb15fcdf173c8de493d639b72
bibliographicCitation	Murray PT, Reddy BV, Grossman EJ, Hammes MS, Trevino S, Ferrell J, Tang I, Hursting MJ, Shamp TR, Swan SK. A prospective comparison of three argatroban treatment regimens during hemodialysis in end-stage renal disease. Kidney Int. 2004 Dec;66(6):2446–53. doi: 10.1111/j.1523-1755.2004.66022.x. PMID: 15569338.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_162e44bd7d7eb67ba55570de5a277ecf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5eda803976b3473126b8bc4242f109b4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8facaa389bd83e1074ce7c9663e9ff56 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_293c017ddaa0930c432e5bea2012c515 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a083fa16c6e8231f5cf138cb7f8e4186 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cc4b841de82a57bf51ab81d32d25bf44 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d01363bbd5b9e9c3a5af88973f10ee7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c874b9a0a13f23349b2e34d589136289 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4e5d7cd0cb9d4af7d2fbf4ee41bbe17 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dd5a690ff742c5f111acbcab74c85898
date	200412
identifier	https://pubmed.ncbi.nlm.nih.gov/15569338 https://doi.org/10.1111/j.1523-1755.2004.66022.x
isPartOf	https://portal.issn.org/resource/ISSN/0085-2538 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5428
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	A prospective comparison of three argatroban treatment regimens during hemodialysis in end-stage renal disease
discusses	http://id.nlm.nih.gov/mesh/M0100029 http://id.nlm.nih.gov/mesh/M0020790 http://id.nlm.nih.gov/mesh/M0016880 http://id.nlm.nih.gov/mesh/M0001683 http://id.nlm.nih.gov/mesh/M0001380
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000925Q000008 http://id.nlm.nih.gov/mesh/D007676Q000628 http://id.nlm.nih.gov/mesh/D010875Q000008 http://id.nlm.nih.gov/mesh/D013927Q000517 http://id.nlm.nih.gov/mesh/D006435Q000379
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D010875Q000009 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000925Q000493 http://id.nlm.nih.gov/mesh/D018592 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D006435Q000592 http://id.nlm.nih.gov/mesh/D001120Q000031 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D000925Q000009 http://id.nlm.nih.gov/mesh/D010875Q000493 http://id.nlm.nih.gov/mesh/D013449 http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D013927Q000188
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1176 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8236 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9412 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92722 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.21.5

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135856263

Total number of triples: 62.